Crossmark

The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

Crossref DOI link: https://doi.org/10.1186/s12885-018-5163-2

Published Online: 2018-12-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Que, Y

Xiao, W

Xu, BS

Wen, XZ

Weng, DS

Zhang, X
Funding

Funding for this research was provided by:

National Basic Research Program of China (2013CB910500)

National Scientific Foundation of China (81572403, 81772863)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 23 May 2018

Accepted: 29 November 2018

First Online: 13 December 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.